Latest filings (excl ownership)
6-K
Current report (foreign)
24 Apr 24
EFFECT
Notice of effectiveness
23 Apr 24
POS AM
Prospectus update (post-effective amendment)
18 Apr 24
6-K
Current report (foreign)
8 Apr 24
20-F
2023 FY
Annual report (foreign)
8 Apr 24
6-K
Current report (foreign)
4 Apr 24
6-K
Current report (foreign)
3 Apr 24
424B5
Prospectus supplement for primary offering
2 Apr 24
6-K
Current report (foreign)
2 Apr 24
6-K
Current report (foreign)
21 Mar 24
6-K
Current report (foreign)
20 Mar 24
6-K
Current report (foreign)
14 Mar 24
6-K
Current report (foreign)
11 Mar 24
6-K
Current report (foreign)
5 Mar 24
6-K
Current report (foreign)
20 Feb 24
6-K
Current report (foreign)
20 Feb 24
EFFECT
Notice of effectiveness
16 Feb 24
CORRESP
Correspondence with SEC
15 Feb 24
UPLOAD
Letter from SEC
14 Feb 24
6-K
Current report (foreign)
13 Feb 24
D
$10.00 mm in equity / options / securities to be acquired, sold $10.00 mm, 5 investors
5 Feb 24
6-K
Current report (foreign)
26 Jan 24
6-K
Current report (foreign)
26 Jan 24
424B5
Prospectus supplement for primary offering
26 Jan 24
6-K
Current report (foreign)
25 Jan 24
6-K
Current report (foreign)
25 Jan 24
6-K
Current report (foreign)
20 Dec 23
6-K
Current report (foreign)
12 Dec 23
6-K
Current report (foreign)
6 Dec 23
6-K
Current report (foreign)
4 Dec 23
6-K
Current report (foreign)
1 Dec 23
6-K
Current report (foreign)
27 Nov 23
6-K
Current report (foreign)
16 Nov 23
6-K
Current report (foreign)
14 Nov 23
EFFECT
Notice of effectiveness
27 Oct 23
424B3
Prospectus supplement
26 Oct 23
CORRESP
Correspondence with SEC
26 Oct 23
F-3/A
Shelf registration (foreign) (amended)
23 Oct 23
6-K
Current report (foreign)
16 Oct 23
F-3
Shelf registration (foreign)
13 Oct 23
Latest ownership filings
SC 13G
INTRACOASTAL CAPITAL, LLC
2 Feb 24
SC 13G
CVI Investments, Inc.
1 Feb 24
SC 13G/A
Empery Asset Management, LP
8 Jan 24
SC 13G/A
SABBY MANAGEMENT, LLC
2 Jan 24
SC 13G
Empery Asset Management, LP
13 Jan 23
SC 13G
SABBY MANAGEMENT, LLC
4 Jan 23
SC 13G
Cosmo Pharmaceuticals N.V.
7 Mar 22
SC 13G/A
Ibex Investors LLC
27 Jan 22
SC 13G/A
Ibex Investors LLC
15 Jan 21
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
SC 13G/A
RedHill Biopharma Ltd.
27 Jan 20
SC 13G
RedHill Biopharma Ltd.
17 Jun 19
SC 13G/A
RedHill Biopharma Ltd.
19 Feb 19
SC 13G
RedHill Biopharma Ltd.
19 Feb 19
SC 13G/A
RedHill Biopharma Ltd.
14 Feb 19
SC 13G
RedHill Biopharma Ltd.
6 Aug 18
SC 13G
RedHill Biopharma Ltd.
16 Jan 18
SC 13G/A
RedHill Biopharma Ltd.
13 Feb 17
SC 13G/A
RedHill Biopharma Ltd.
10 Feb 17
SC 13G
RedHill Biopharma Ltd.
6 Jan 17
SC 13G
RedHill Biopharma Ltd.
29 Dec 16
SC 13G
RedHill Biopharma Ltd.
25 Nov 16
SC 13D/A
RedHill Biopharma Ltd.
16 Feb 16
SC 13G/A
RedHill Biopharma Ltd.
16 Feb 16
SC 13G/A
RedHill Biopharma Ltd.
16 Feb 16
SC 13G/A
RedHill Biopharma Ltd.
16 Feb 16
SC 13G/A
RedHill Biopharma Ltd.
16 Feb 16
SC 13G/A
RedHill Biopharma Ltd.
12 Feb 16
SC 13G/A
RedHill Biopharma Ltd.
11 Feb 16
SC 13G/A
RedHill Biopharma Ltd.
3 Feb 16
SC 13G
RedHill Biopharma Ltd.
8 Jun 15
SC 13G
RedHill Biopharma Ltd.
26 Feb 15
SC 13G/A
RedHill Biopharma Ltd.
17 Feb 15
SC 13G/A
RedHill Biopharma Ltd.
13 Feb 15
SC 13G/A
RedHill Biopharma Ltd.
13 Feb 15
SC 13G/A
RedHill Biopharma Ltd.
13 Feb 15
SC 13G/A
RedHill Biopharma Ltd.
13 Feb 15
SC 13G
RedHill Biopharma Ltd.
9 Feb 15
SC 13G/A
RedHill Biopharma Ltd.
21 Jan 15
SC 13G/A
RedHill Biopharma Ltd.
10 Feb 14